Collectively, these studies indicate that the extrinsic pro-tumor effect associated with NKG2D–NKG2D ligand signaling is not restricted to HCC and could broadly apply to cancer driven by chronic inflammation. This evidence concerns the gene KLRK1 and neoplasm.